Zai Lab (ZLAB) Intangibles (2016 - 2026)
Zai Lab (ZLAB) posted quarterly Intangibles of $75.8 million for Q1 2026, up 34.81% year-on-year from $56.2 million in Q1 2025, and down 0.51% on a QoQ basis from $76.1 million in Q4 2025.
Zai Lab (ZLAB) Intangibles (2016 - 2026) Analysis & Trends
Zai Lab (ZLAB) has reported Intangibles for 11 consecutive years, with $75.8 million the latest figure, recorded in Q1 2026.
- Quarterly Intangibles rose 34.81% year-over-year to $75.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $75.8 million (up 34.81% YoY) and the FY2025 annual result came in at $76.1 million, up 35.91% from the prior year.
- Intangibles fell to $75.8 million in Q1 2026 per ZLAB's latest filing, from $76.1 million in the prior quarter.
- Over the last five years, Intangibles for ZLAB reached as high as $76.1 million in Q4 2025 and fell as low as $1.5 million in Q1 2023.
- A 5-year average of $29.9 million and a median of $13.4 million in 2023 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2022 — Intangibles retreated 18.24% — and 2024, when it surged 3195.22%.
- Year by year, Intangibles stood at $1.5 million in 2022, then soared by 786.1% to $13.4 million in 2023, then soared by 318.46% to $56.0 million in 2024, then surged by 35.91% to $76.1 million in 2025, then retreated by 0.51% to $75.8 million in 2026.
- According to Business Quant data, Intangibles over the past three periods registered $75.8 million, $76.1 million, and $55.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 11,640.44 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 61.68 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.92 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 266.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 55.80 Mn |
| 10 | Zai Lab | 22.02 Bn | 22.02 Bn | 61.30 Mn | 75.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 75.76 Mn |
| Dec 31, 2025 | 76.14 Mn |
| Sep 30, 2025 | 55.28 Mn |
| Jun 30, 2025 | 56.52 Mn |
| Mar 31, 2025 | 56.20 Mn |
| Dec 31, 2024 | 56.03 Mn |
| Sep 30, 2024 | 51.67 Mn |
| Jun 30, 2024 | 44.06 Mn |
| Mar 31, 2024 | 12.40 Mn |
| Dec 31, 2023 | 13.39 Mn |
| Sep 30, 2023 | 1.57 Mn |
| Jun 30, 2023 | 1.69 Mn |
| Mar 31, 2023 | 1.48 Mn |
| Dec 31, 2022 | 1.51 Mn |
| Sep 30, 2022 | 1.54 Mn |
| Jun 30, 2022 | 1.67 Mn |
| Mar 31, 2022 | 1.75 Mn |
| Dec 31, 2021 | 1.85 Mn |
| Sep 30, 2021 | 1.68 Mn |
| Jun 30, 2021 | 1.73 Mn |